Abstract Library

#1272 Telotristat Etiprate Appears to Halt Carcinoid Heart Disease

Introduction: Carcinoid Heart Disease (CHD) is a serious complication of the Carcinoid Syndrome (in as many as 50% of patients during the course of their disease). 46% of cases operated with bioprosthetic valves develop recurrent carcinoid valvulopathy on the newly implanted tissue valves. Until now, only mechanical prosthetic valves avoid recurrent fibrosis.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Zacks J

Authors: Zacks J, Lavine R, Ratner L, Warner R,

Keywords: carcinoid heart disease, valve, heart failure, carcinoid syndrome, prosthetic valves, telotristat etiprate,

#1041 Surgical Management of Carcinoid Valve Disease-Mechanical versus Tissue Valves

Introduction: The prosthetic valve of choice in patients with carcinoid valve disease (CVD) remains controversial due to the limited life expectancy of patients with advanced-stage neuroendocrine tumors (NETs) on one hand, and concerns regarding structural valve deterioration (SVD) on the other.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Glasberg S

Authors: Glasberg S, Atlan J, Korach A, Dabah A, Atlan K,

Keywords: carcinoid valve disease,